SPONSOR
China National Center for Cardiovascular Diseases
Total Trials
5
Recruiting
5
Phases
Phase 4
Conditions studied: Atrial FibrillationAnticoagulant Adverse ReactionStrokeMajor Adverse Cardiac EventsElevated Lipoprotein(a) LevelCoronary Artery DiseaseDrug-Eluting StentDual Antiplatelet TherapyCoronary Heart DiseaseAcute Coronary Syndrome
China National Center for Cardiovascular Diseases is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Atrial Fibrillation, Anticoagulant Adverse Reaction, Stroke, Major Adverse Cardiac Events.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — China National Center for Cardiovascular Diseases
How many clinical trials has China National Center for Cardiovascular Diseases sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by China National Center for Cardiovascular Diseases, of which 5 are actively recruiting participants. These trials cover conditions including Atrial Fibrillation, Anticoagulant Adverse Reaction, Stroke. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does China National Center for Cardiovascular Diseases research focus on?
China National Center for Cardiovascular Diseases clinical trials span Atrial Fibrillation, Anticoagulant Adverse Reaction, Stroke, Major Adverse Cardiac Events, Elevated Lipoprotein(a) Level, and additional conditions. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a China National Center for Cardiovascular Diseases clinical trial?
To participate in a China National Center for Cardiovascular Diseases trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all China National Center for Cardiovascular Diseases trials with current recruitment status updated daily.
Clinical Trials by China National Center for Cardiovascular Diseases
NCT06108414 Phase 4
Recruiting
Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation
Atrial Fibrillation
NCT06014060
Recruiting
24 Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent in Patients With Elevated Lipoprotein(a) Levels: A Prospective, Multicenter, Double-Blind, Placebo-Controlled Randomized Trial
Elevated Lipoprotein(a) Level
NCT07230847
Recruiting
A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug-coated Stents and the Xience Drug-eluting Stent System in Patients With Acute Coronary Syndrome and High Bleeding Risk Using Optical Coherence Tomography
Coronary Heart Disease
NCT06347276
Recruiting
Cerebral Microembolization Associated With PFO Closure
Thrombosis Cardiac
NCT05638867 Phase 4
Recruiting
NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI
Coronary Artery Disease
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology